Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative

Molecular Carcinogenesis

Volumn 48, Issue 8, 2009, Pages 692-702

  Jutooru, Indira ^a   Chadalapaka, Gayathri ^a   Chintharlapalli, Sudhakar ^b   Papineni, Sabitha ^b   Safe, Stephen ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Apoptosis; CDODA Me; Pancreatic cancer

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CYCLIN D1; EARLY GROWTH RESPONSE FACTOR 1; GLYCYRRHETINIC ACID DERIVATIVE; METHYL 2 CYANO 3,11 DIOXO 18B OLEAN 1,12 DIEN 30 OATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; DRUG DERIVATIVE; GDF15 PROTEIN, HUMAN; GLYCYRRHETINIC ACID; GROWTH DIFFERENTIATION FACTOR 15; LUCIFERASE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE; GENE INDUCTION; HUMAN; HUMAN CELL; NONSTEROIDAL ANTIINFLAMMATORY DRUG ACTIVATED GENE 1; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ADIPOSE TISSUE; ANIMAL; CYTOLOGY; DRUG EFFECT; GENETIC TRANSFECTION; METABOLISM; MOUSE; PANCREAS TUMOR; PATHOLOGY; PROMOTER REGION; TUMOR CELL CULTURE; WESTERN BLOTTING;

GLYCYRRHIZA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTIVATING TRANSCRIPTION FACTOR 3; ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 1; GLYCYRRHETINIC ACID; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; LUCIFERASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC NEOPLASMS; PPAR GAMMA; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 68849092589     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20518     Document Type: Article

References (39)

1. Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol 2005;99:317-324. (Pubitemid 40854146)
2. Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes 2002;110:257-261.
3. Whorwood CB, Sheppard MC, Stewart PM. Licorice inhibits 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 1993;132:2287-2292.
4. Armanini D, De Palo CB, Mattarello MJ, et al. Effect of licorice on the reduction of body fat mass in healthy subjects. J Endocrinol Invest 2003;26:646-650. (Pubitemid 37270696)
5. Baltina LA. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine. Curr Med Chem 2003;10:155-171.
6. Honda T, Gribble GW, Suh N, et al. Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages. J Med Chem 2000;43:1866-1877. (Pubitemid 30305019)
7. Honda T, Rounds BV, Gribble GW, et al. Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages. Bioorg Med Chem Lett 1998;8:2711-2714. (Pubitemid 28496657)
8. Honda T, Finlay HJ, Gribble GW, Suh N, Sporn MB. New enone derivatives of oleanolic acid and ursolic acid as inhibitors of nitric oxide production in mouse macrophages. Bioorg Med Chem Lett 1997;7:1623-1628. (Pubitemid 27321473)
9. Vannini N, Lorusso G, Cammarota R, et al. The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent. Mol Cancer Ther 2007;6:3139-3146.
10. Ling X, Konopleva M, Zeng Z, et al. The novel triterpenoid C- 28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling. Cancer Res 2007;67:4210-4218. (Pubitemid 46815067)
11. Chintharlapalli S, Papineni S, Jutooru I, McAlees A, Safe S. Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor γ (PPARγ) agonists in colon cancer cells. Mol Cancer Therap 2007;6:1588-1598.
12. Papineni S, Chintharlapalli S, Safe S. Methyl 2-cyano-3,11- dioxo-18β-olean-1,12-dien-30-oate is a peroxisome proliferator- activated receptor γ agonist that induces receptor-independent apoptosis in LNCaP prostate cancer cells. Mol Pharmacol 2008;73:553-565. (Pubitemid 351159224)
13. Chadalapaka G, Jutooru I, McAlees A, Stefanac T, Safe S. Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives. Bioorg Med Chem Lett 2008;18:2633-2639.
14. Elnemr A, Ohta T, Iwata K, et al. PPARγ ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells. Int J Oncol 2000;17:1157-1164.
15. Itami A, Watanabe G, Shimada Y, et al. Ligands for peroxisome proliferator-activated receptor γ inhibit growth of pancreatic cancers both in vitro and in vivo. Int J Cancer 2001;94:370-376. (Pubitemid 32906067)
16. KiP1 in human pancreatic carcinoma cells. Cancer Res 2000;60:5558-5564.
17. Hong J, Samudio I, Liu S, Abdelrahim M, Safe S. Peroxisome proliferator-activated receptor γ-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. Endocrinology 2004;145:5774-5785. (Pubitemid 39564619)
18. Abdelrahim M, Newman K, Vanderlaag K, Samudio I, Safe S. 3,3′-Diindolylmethane (DIM) and derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. Carcinogenesis 2006;27:717-728.
19. Samudio I, Konopleva M, Hail N Jr, et al. 2-Cyano-3,12 dioxooleana-1,9 diene-28-imidazolide (CDDO-Im) directly targets mitochondrial glutathione to induce apoptosis in pancreatic cancer. J Biol Chem 2005;280:36273-36282.
20. Motomura W, Nagamine M, Tanno S, et al. Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells. J Gastroenterol 2004;39: 461-468. (Pubitemid 38811730)
21. Ohta T, Elnemr A, Yamamoto M, et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-γ ligand, modulates the E-cadherin/β-catenin system in a human pancreatic cancer cell line, BxPC-3. Int J Oncol 2002;21:37-42.
22. Motomura W, Tanno S, Takahashi N, et al. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells. Biochem Biophys Res Commun 2005;332:89-94. (Pubitemid 40719461)
23. Hashimoto K, Farrow BJ, Evers BM. Activation and role of MAP kinases in 15d-PGJ2-induced apoptosis in the human pancreatic cancer cell line MIA PaCa-2. Pancreas 2004;28: 153-159. (Pubitemid 38269775)
24. Farrow B, Evers BM. Activation of PPARγ increases PTEN expression in pancreatic cancer cells. Biochem Biophys Res Commun 2003;301:50-53. (Pubitemid 36268846)
25. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclo-oxygenase inhibitors regulate the expression of a TGF-β superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001;59:901-908.
26. Baek SJ, Kim JS, Moore SM, et al. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol 2005;67:356-364.
27. Lee SH, Cekanova M, Baek SJ. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol Carcinog 2008;47:197-208.
28. Lee SH, Yamaguchi K, Kim JS, et al. Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 2006;27:972-981.
29. Lim JH, Park JW, Min DS, et al. NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 2007; 12:411-421.
30. Soto-Cerrato V, Vinals F, Lambert JR, Kelly JA, Perez-Tomas R. Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3beta activity in human breast cancer cells. Mol Cancer Ther 2007;6:362-369. (Pubitemid 46206701)
31. Pang RP, Zhou JG, Zeng ZR, et al. Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/ GSK3beta/NAG-1 pathway. Cancer Lett 2007;251:268-277. (Pubitemid 46671612)
32. Shim M, Eling TE. Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. J Biol Chem 2005; 280:18636-18642. (Pubitemid 41379563)
33. Chen YL, Lin PC, Chen SP, et al. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone- triggered apoptotic pathway in human lung cancer A549 cells. J Pharmacol Exp Ther 2007; 323:746-756.
34. Baek SJ, Wilson LC, Hsi LC, Eling TE. Troglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) ligand, selectively induces the early growth response-1 gene independently of PPARγ. A novel mechanism for its antitumorigenic activity. J Biol Chem 2003;278:5845-5853.
35. Chintharlapalli S, Papineni S, Baek SJ, Liu S, Safe S. 1,1-Bis(3′- indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor gamma agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response- 1 and NAG-1. Mol Pharmacol 2005;68:1782-1792.
36. Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE. Expression of NAG-1, a transforming growth factor-β superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 2004;279:6883-6892.
37. Ikezoe T, Miller CW, Kawano S, et al. Mutational analysis of the peroxisome proliferator-activated receptor γ gene in human malignancies. Cancer Res 2001;61:5307-5310. (Pubitemid 32681569)
38. Grommes C, Landreth GE, Heneka MT. Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists. Lancet Oncol 2004;5:419-429. (Pubitemid 38878045)
39. Chintharlapalli S, Papineni S, Liu S, et al. 2-Cyano-lup-1-en- 3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor γ in colon and pancreatic cancer cells. Carcinogenesis 2007;28: 2337-2346. (Pubitemid 350111592)